WebMD is a leading provider of health information for both patients and healthcare professionals.

Many factors affect our cardiovascular health and these can be magnified when diabetes is involved. One often overlooked factor is Heart Rate Variability (HRV). When I first read this week’s feature from Sheri Colberg, all I could think of was how high my heart rate goes when I get in …

FDA Approves 2nd Weight Loss Product See this week’s Item #3, FDA Approves Phentermine-Topiramate Combo for Weight Loss.

SurroSense Rx Wireless Shoe Insert  The SurroSense Rx is a high-tech, pressure-sensing insole and wristband that tells the user when damage is being done to the feet. The product is designed to mitigate diabetic foot complications, such as ulceration, infection and amputation. Patients are often unaware when pressure thresholds are …

Data on 2,704 adults with diabetes showed about 100% of those age 65 and older had health insurance, compared with only 85% of those 18 to 64 years old. About two million diabetes patients under the age of 65 had no health insurance coverage. Health insurance costs were the main …

Investment firm Merrill Lynch reports that more than 50 companies could benefit. Drug producers, the food sector, diet and related products, and the sport apparel and equipment sectors will benefit the most. A CDC-funded study said that about one-third of American adults are obese and another one-third overweight. The percentage …

A new Commonwealth Fund report shows that US women are in much worse shape, healthcare-wise, than women in 10 nations that have universal healthcare. Even insured American women are more likely to go without needed healthcare because of the cost and difficulty paying medical bills. Published online July 13, 2012 

A bigger waistline, coinciding with a higher risk of cardio-metabolic complications in type 2 diabetes patients, suggests that waist measurement is critical for this population….

A study lead by researchers from Brigham and Women’s Hospital (BWH) shows an association between increased concentrations of….

The FDA has approved the weight-loss drug Qsymia, formerly Qnexa, which now joins lorcaserin (Belviq), as the first anti-obesity medications to enter the US market since 1999….